|
DE10207843A1
(de)
*
|
2002-02-15 |
2003-09-04 |
Schering Ag |
Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen
|
|
CN101899006B
(zh)
*
|
2002-08-19 |
2013-11-06 |
劳洛斯治疗公司 |
2，4，5-三取代的咪唑及其作为抗菌剂的用途
|
|
WO2004035549A1
(en)
|
2002-10-17 |
2004-04-29 |
Amgen Inc. |
Benzimidazole derivatives and their use as vanilloid receptor ligands
|
|
WO2005047266A1
(en)
|
2003-11-14 |
2005-05-26 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
|
DE102004026590A1
(de)
*
|
2004-06-01 |
2006-01-12 |
Siemens Ag |
Assistenzsystem für Kraftfahrzeuge
|
|
US7538113B2
(en)
|
2005-02-18 |
2009-05-26 |
Wyeth |
4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
|
US7534796B2
(en)
|
2005-02-18 |
2009-05-19 |
Wyeth |
Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
|
|
US7582634B2
(en)
|
2005-02-18 |
2009-09-01 |
Wyeth |
7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
|
US7531542B2
(en)
|
2005-05-18 |
2009-05-12 |
Wyeth |
Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
|
|
EP1915374B1
(en)
|
2005-05-25 |
2014-04-02 |
Lorus Therapeutics Inc. |
2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
|
|
US7582636B2
(en)
|
2005-05-26 |
2009-09-01 |
Wyeth |
Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
|
|
WO2010036908A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Eisai R & D Management Co., Ltd. |
Use of benzoxazole compounds in the treatment of malaria
|
|
WO2010036905A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Eisai R & D Management Co., Ltd. |
Benzoxazole compounds and methods of use
|
|
US20120263646A1
(en)
*
|
2009-10-15 |
2012-10-18 |
Guerbet |
Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
|
|
KR20160042811A
(ko)
|
2013-03-20 |
2016-04-20 |
압토스 바이오사이언시스 인코포레이티드 |
2-치환 이미다조[4,5-d]페난쓰롤린 유도체 및 암 치료에 있어서의 이의 용도
|
|
WO2015051302A1
(en)
|
2013-10-04 |
2015-04-09 |
Aptose Biosciences Inc. |
Compositions and methods for treating cancers
|
|
PL3390367T3
(pl)
*
|
2015-12-15 |
2021-03-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Sposób zapobiegania zaburzeniom poznawczym związanym z wiekiem i zapaleniu tkanki nerwowej lub ich leczenia
|
|
CN111417395A
(zh)
|
2017-10-30 |
2020-07-14 |
艾普托斯生物科学公司 |
用于治疗癌症的芳基咪唑
|
|
BR112021002165A2
(pt)
*
|
2018-08-06 |
2021-05-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
composto, composição farmacêutica, e, métodos para tratar uma doença neurodegenerativa e deficiência cognitiva associada ao envelhecimento e neuroinflamação
|